A Phase I/II Study to Evaluate the Safety, Tolerability and Efficacy of PerioSept and Scaling and Root Planing in Subjects With Periodontitis
Phase of Trial: Phase I/II
Latest Information Update: 06 May 2017
At a glance
- Drugs Taurolidine (Primary)
- Indications Periodontitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Geistlich
- 15 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2018.
- 15 Feb 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
- 24 Jul 2015 Planned End Date changed from 1 Feb 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.